These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2908544)

  • 21. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
    Hodaie M; Neimat JS; Lozano AM
    Neurosurgery; 2007 Jan; 60(1):17-28; discussion 28-30. PubMed ID: 17228250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neural transplants en Parkinson disease: clinical results of 10 years of experience. Group of Neural Transplants of the CPH].
    López-Lozano JJ; Mata M; Bravo G
    Rev Neurol; 2000 Jun 1-15; 30(11):1077-83. PubMed ID: 10904957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A year follow-up of autoimplants of perfused adrenal medulla into parkinsonian patients. CPH Neural Transplantation Group.
    Lopez-Lozano JJ; Abascal J; Bravo G
    Prog Brain Res; 1990; 82():657-63. PubMed ID: 2290967
    [No Abstract]   [Full Text] [Related]  

  • 24. Surgical treatment of Parkinson's disease.
    Med Lett Drugs Ther; 1993 Nov; 35(909):103-4. PubMed ID: 8232061
    [No Abstract]   [Full Text] [Related]  

  • 25. Embryonic brain grafts in an animal model of Parkinson's disease. Criteria for human application.
    Freed WJ; Cannon-Spoor HE; Wyatt RJ
    Appl Neurophysiol; 1984; 47(1-2):16-22. PubMed ID: 6508277
    [No Abstract]   [Full Text] [Related]  

  • 26. Grafts correct brain damage.
    Kolata G
    Science; 1982 Jul; 217(4557):342-4. PubMed ID: 7089568
    [No Abstract]   [Full Text] [Related]  

  • 27. New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation.
    Duvoisin RC
    Neurology; 1989 Nov; 39(11 Suppl 2):4-6. PubMed ID: 2573862
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study.
    Watts RL; Subramanian T; Freeman A; Goetz CG; Penn RD; Stebbins GT; Kordower JH; Bakay RA
    Exp Neurol; 1997 Oct; 147(2):510-7. PubMed ID: 9344575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New concepts in Parkinson's disease.
    Sweeney PJ
    Hosp Pract (Off Ed); 1991 Apr; 26(4):84-94. PubMed ID: 1672693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain transplants.
    Robinson RO
    Dev Med Child Neurol; 1983 Oct; 25(5):654-6. PubMed ID: 6354805
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental study on autotransplantation of the adrenal medulla to the brain].
    Wu RQ
    Zhonghua Yi Xue Za Zhi; 1985 Feb; 65(2):95-7. PubMed ID: 3921218
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fetal and adrenal transplantation in Parkinson disease: theoretical bases and clinical results].
    Diederich NJ; Goetz CG
    Bull Soc Sci Med Grand Duche Luxemb; 1993; 130(1):25-36. PubMed ID: 8222013
    [No Abstract]   [Full Text] [Related]  

  • 33. Adrenal medulla transplantation into the putamen in Parkinson's disease.
    Takeuchi J; Takebe Y; Sakakura T; Hara Y; Yasuda T; Imai T
    Neurosurgery; 1990 Mar; 26(3):499-503. PubMed ID: 2320218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive potential of fetal nigral implants for Parkinson disease.
    Rosenberg RN
    Arch Neurol; 2004 Jun; 61(6):837-8. PubMed ID: 15210519
    [No Abstract]   [Full Text] [Related]  

  • 35. The adrenal medullary transplant operation: the Chicago experience. The Rush Research Group and Colleagues.
    Prog Brain Res; 1990; 82():627-35. PubMed ID: 2290964
    [No Abstract]   [Full Text] [Related]  

  • 36. Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease.
    Lang AE; Obeso JA
    Ann Neurol; 2004 Jun; 55(6):761-5. PubMed ID: 15174009
    [No Abstract]   [Full Text] [Related]  

  • 37. [The status of imaging methods for the treatment of patients with Parkinson's syndrome].
    Schwarz J; Gratz S; Hahn U; Förstl H; Jarnig M
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S8-10. PubMed ID: 18437640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenal medullary autograft in human brain for Parkinson's disease.
    Frank F; Sturiale C; Gaist G; Manetto V
    Acta Neurochir (Wien); 1988; 94(3-4):162-3. PubMed ID: 3213637
    [No Abstract]   [Full Text] [Related]  

  • 39. Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies.
    Olson L; Backlund EO; Gerhardt G; Hoffer B; Lindvall O; Rose G; Seiger A; Strömberg I
    Adv Neurol; 1987; 45():85-94. PubMed ID: 3030073
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intracaudate grafting of the adrenal medulla in the treatment of Parkinson's disease].
    Zhang WC; Ding MC; Jiao SS
    Zhonghua Wai Ke Za Zhi; 1988 Jan; 26(1):1-5, 59. PubMed ID: 3197528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.